Searchable abstracts of presentations at key conferences in endocrinology

ea0056p1035 | Thyroid (non-cancer) | ECE2018

The assessment of vitamin D3 deficiency in patients with Hashimoto’s disease and the relationship between the disease duration and 25OHD3 levels

Lizis-Kolus Katarzyna , Hubalewska-Dydejczyk Alicja , Sowa-Staszczak Anna , Skalniak Anna , Kowalska Aldona , Lizis Pawel

The observed increase in the incidence of Hashimoto’s thyroiditis (HT) requires the research on environmental factors that may initiate or model its course. There have been reports of the impact of vitamin D3 deficiency on HT development.Objective: To assess the degree of deficiency of 25OHD3 and the relationship between the disease duration and 25OHD3 levels in patients with HT.Material and methods: 310 people were enrolled i...

ea0099ep313 | Endocrine-Related Cancer | ECE2024

Safety and outcomes of laparoscopic adrenalectomy for metastatic tumors – experience in a high-volume urological center

Niedziela Emilia , Niedziela Łukasz , Jaskulski Jarosław , Obarzanowski Mateusz , Kowalska Aldona

Introduction: In case of isolated adrenal metastases, complete surgical resection of the disease is a potentially curative treatment. Minimally invasive adrenalectomy is recommended in most patients with focal adrenal lesions without evidence of local invasion. However, data on surgical outcomes and survival after laparoscopic adrenalectomy (LA) for adrenal metastases are still lacking to clearly define the role of this procedure in the management of metastatic disease. <p...

ea0099ep1127 | Endocrine-Related Cancer | ECE2024

A case study of managing a patient with bilateral pheochromocytoma in the 21st week of pregnancy

Przybycień Piotr , Gąsior-Perczak Danuta , Jaskulski Jarosław , Kowalska Aldona

Introduction: Pheochromocytomas are rarely diagnosed in pregnancy. The consequences of pheochromocytoma during pregnancy can be devastating for both mother and fetus. Effective treatment requires an accurate and early diagnosis, but sometimes the tumor is diagnosed relatively late, so it is absolutely necessary to respond quickly and effectively.Purpose: The aim of our study is to describe a patient with a history of medullary thyroid cancer who underwen...

ea0049ep1409 | Thyroid (non-cancer) | ECE2017

Does the delayed risk stratification system help to evaluate the risk of unfavorable clinical outcome in pT1aN0/Nx stage patients with differentiated thyroid cancer treated without radioactive iodine?

Gasior-Perczak Danuta , Palyga Iwona , Szymonek Monika , Walczyk Agnieszka , Kopczynski Janusz , Sluszniak Anna , Mezyk Ryszard , Gozdz Stanislaw , Kowalska Aldona

Introduction: In ATA recommendations (2016) a delayed risk stratification (DRS) system proposed by D.P. Momesso et al. was accepted as a diagnostic tool for the risk stratification of unfavorable clinical outcome and for monitoring the clinical outcome in differentiated thyroid cancer (DTC) patients treated without radioactive iodine (RAI).The aim of the study: To evaluate the DRS system in patients with low clinical stage (pT1aN0/Nx).<p class="abste...

ea0035p1144 | Thyroid Cancer | ECE2014

Coexistence of mutations in the CHEK2 and BRAFV600E genes and their impact on the course of the papillary thyroid carcinoma (PTC)

Gasior-Perczak Danuta , Kowalska Aldona , Palyga Iwona , Walczyk Agnieszka , Siolek Monika , Kowalik Artur , Mezyk Ryszard , Gozdz Stanislaw

Introduction: The activating BRAFV600E is the most common genetic alteration in PTC. There is a common belief that it can correlate with a more aggressive clinical course. The mutation of the CHEK2 gene impairs the repair processes of the damaged DNA. It can be expected that the coexistence of both mutations can be related to a worse clinical course.Aim: To assess the prevalence of the coexistence of the CHEK2 and BRAFV600E mutation...

ea0035p1145 | Thyroid Cancer | ECE2014

Impact of different methods on the detection frequency of BRAF mutation in papillary thyroid carcinoma

Kowalik Artur , Kowalska Aldona , Kopczynski Janusz , Walczyk Agnieszka , Nowak Ewelina , Wypiorkiewicz Elzbieta , Chodurska Renata , Pieciak Liliana , Gozdz Stanislaw

Introduction: Still there is a discussion about the importance of diagnostic and prognostic relevance BRAFV600E mutation. The wide range of BRAFV600E mutation frequency (40–80%) doesn’t facilitate this task. Population diversity and genotyping methodology are suspected sources of differences seen in the mutation frequencies detected by different studies. The aim of this study was to assess the prevalence BRAF V600...

ea0035p1147 | Thyroid Cancer | ECE2014

Occurrence other than V600E mutation in the BRAF gene in papillary thyroid carcinoma

Kowalik Artur , Kowalska Aldona , Kopczynski Janusz , Walczyk Agnieszka , Nowak Ewelina , Wypiorkiewicz Elzbieta , Chodurska Renata , Pieciak Liliana , Gozdz Stanislaw

Introduction: BRAFV600E mutation constitutes 98–99% of all detected mutation in thyroid carcinoma. The remaining 2% are BRAF mutations detected in the vicinity of codon V600. Due to the low incidence not much is known about their importance for the development of papillary thyroid carcinoma (PTC). In addition, some of these mutations co-occur with the mutation BRAFV600E.Methods/design: The study prese...

ea0022p245 | Clinical case reports and clinical practice | ECE2010

The course of disease and treatment of patient with MEN2A syndrome diagnosed in 9-th week of pregnancy

Kowalska Aldona , Palyga Iwona , Gasior-Perczak Danuta , Chlosta Piotr , Sluszniak Janusz , Kowalik Artur , Walkowski Jacek , Gozdz Stanislaw

Introduction: Diagnosis of pheochromocytoma is rarely established in pregnancy, although can cause threat to health and life of foetus and mother. Exact and early diagnosis is crucial for effective treatment.Purpose: The purpose of our study is to present a case of patient with pheochromocytoma and medullary thyroid carcinoma (MCT) – MEN2A syndrome - diagnosed in 9-th week of pregnancy.Material and method: Twenty nine-year-old...

ea0099p573 | Thyroid | ECE2024

Focal thyroid incidentalomas in 18F-PSMA PET/CT – a retrospective analysis of incidence and clinical significance

Niedziela Emilia , Niedziela Łukasz , Palyga Iwona , Kopczyński Janusz , Jaskulski Jarosław , Braziewicz Janusz , Kowalska Aldona

Introduction: 18F- Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography (18F-PSMA PET/CT) is currently used in the evaluation of prostate cancer. Due to increased expression of PSMA in the neovascular endothelial cells of malignant lesions other than prostate cancer, PSMA PET/CT has become of interest to researchers in the management of thyroid cancer. The goal of this study was to evaluate the incidence and clinical signifi...

ea0099ep1128 | Endocrine-Related Cancer | ECE2024

A case report of a 69-year-old patient with a paraganglioma metastasis to the thyroid gland

Piechota Karolina , Gąsior-Perczak Danuta , Przybycień Piotr , Kopczyński Janusz , Kowalik Artur , Gozdz Stanislaw , Kowalska Aldona

Introduction: Paragangliomas are rare neuroendocrine neoplasms arising from chromaffin cells in the sympathetic or parasympathetic neural paraganglia that may appear in many places throughout the body. These might be benign or malignant tumors. We report an interesting case of disseminated paraganglioma, the diagnosis of which began with the metastasis to the thyroid gland.Case presentation: A 69-year-old patient with a history of toxic multinodular goit...